|
1. Northfelt, D.W., et al., Doxorubicin encapsulated in liposomes containing surface-bound polyethylene glycol: pharmacokinetics, tumor localization, and safety in patients with AIDS-related Kaposi's sarcoma. J Clin Pharmacol, 1996. 36(1): p. 55-63. 2. Xiao, W., et al., Co-delivery of doxorubicin and plasmid by a novel FGFR-mediated cationic liposome. Int J Pharm, 2010. 393(1-2): p. 119-26. 3. Angioli, R., et al., Liposome-encapsulated doxorubicin citrate in previously treated recurrent/metastatic gynecological malignancies. Int J Gynecol Cancer, 2007. 17(1): p. 88-93. 4. Poirier, V.J., et al., Liposome-encapsulated doxorubicin (Doxil) and doxorubicin in the treatment of vaccine-associated sarcoma in cats. J Vet Intern Med, 2002. 16(6): p. 726-31. 5. Oja, C., et al., Doxorubicin entrapped within liposome-associated antigens results in a selective inhibition of the antibody response to the linked antigen. Biochimica Et Biophysica Acta, 2000. 1468(1-2): p. 31-40. 6. Shinozawa, S., Y. Araki, and T. Oda, Tissue distribution and antitumor effect of liposome-entrapped doxorubicin (adriamycin) in Ehrlich solid tumor-bearing mouse. Acta Med Okayama, 1981. 35(6): p. 395-405. 7. Forssen, E.A. and Z.A. Tokes, Attenuation of dermal toxicity of doxorubicin by liposome encapsulation. Cancer Treat Rep, 1983. 67(5): p. 481-4. 8. Gabizon, A., A. Meshorer, and Y. Barenholz, Comparative long-term study of the toxicities of free and liposome-associated doxorubicin in mice after intravenous administration. J Natl Cancer Inst, 1986. 77(2): p. 459-69. 9. Mayhew, E.G., et al., Effects of liposome-entrapped doxorubicin on liver metastases of mouse colon carcinomas 26 and 38. J Natl Cancer Inst, 1987. 78(4): p. 707-13. 10. Storm, G., et al., Potential pitfalls in in vitro antitumor activity testing of free and liposome-entrapped doxorubicin. J Pharm Sci, 1988. 77(10): p. 823-30.
11. Khang, G., et al., Fabrication of tubular porous PLGA scaffold by emulsion freeze-drying method. Polymer-Korea, 1999. 23(3): p. 471-477. 12. Jalil, R. and J.R. Nixon, Biodegradable poly(lactic acid) and poly(lactide-co-glycolide) microcapsules: problems associated with preparative techniques and release properties. J Microencapsul, 1990. 7(3): p. 297-325. 13. Heller, J., Controlled drug release from poly(ortho esters). Ann N Y Acad Sci, 1985. 446: p. 51-66. 14. Heller, J., Controlled Release of Biologically-Active Compounds from Bioerodible Polymers. Biomaterials, 1980. 1(1): p. 51-57. 15. Dixit, V., et al., Functional characteristics of primary rat hepatocytes in monolayers and on three-dimensional PLGA scaffold. Gastroenterology, 1999. 116(4): p. A1204-A1204. 16. Oh, J.H., In vivo comparison of corneal substitutes using PLGA scaffold, Type I collagen film, Type I collagen film combined with amniotic membrane and lyophilized homologous cornea. Investigative Ophthalmology & Visual Science, 2002. 43: p. U1190-U1190. 17. Astete, C.E. and C.M. Sabliov, Synthesis and characterization of PLGA nanoparticles. J Biomater Sci Polym Ed, 2006. 17(3): p. 247-89. 18. Kitchell, J.P. and D.L. Wise, Poly(lactic/glycolic acid) biodegradable drug-polymer matrix systems. Methods Enzymol, 1985. 112: p. 436-48. 19. Cohen, S., M.J. Alonso, and R. Langer, Novel approaches to controlled-release antigen delivery. Int J Technol Assess Health Care, 1994. 10(1): p. 121-30. 20. Zwelling, L.A., et al., Protein-associated deoxyribonucleic acid strand breaks in L1210 cells treated with the deoxyribonucleic acid intercalating agents 4'-(9-acridinylamino) methanesulfon-m-anisidide and adriamycin. Biochemistry, 1981. 20(23): p. 6553-63. 21. Nelson, E.M., K.M. Tewey, and L.F. Liu, Mechanism of antitumor drug action: poisoning of mammalian DNA topoisomerase II on DNA by 4'-(9-acridinylamino)-methanesulfon-m-anisidide. Proc Natl Acad Sci U S A, 1984. 81(5): p. 1361-5.
22. Janes, K.A., et al., Chitosan nanoparticles as delivery systems for doxorubicin. Journal of Controlled Release, 2001. 73(2-3): p. 255-267. 23. Wang, Z., Effects of the Process Parameters on the Initial Burst Release of Poly(lactide-co-glycolide) Microspheres Containing Bovine Serum Albumin by the Double-Emulsion Solvent Evaporation/Extraction Method. Journal of Applied Polymer Science, 2010. 115(5): p. 2599-2608. 24. Jeffery, H., S.S. Davis, and D.T. Ohagan, The Preparation and Characterization of Poly(Lactide-Co-Glycolide) Microparticles .1. Oil-in-Water Emulsion Solvent Evaporation. International Journal of Pharmaceutics, 1991. 77(2-3): p. 169-175. 25. Li, Z., et al., Bovine Serum Albumin Loaded Solid Lipid Nanoparticles Prepared by Double Emulsion Method. Chemical Research in Chinese Universities, 2010. 26(1): p. 136-141. 26. Yang, Y.Y., et al., Effect of preparation conditions on morphology and release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion method. Chemical Engineering Science, 2000. 55(12): p. 2223-2236. 27. Van Grieken, R.E. Markowicz, A.AHandbook of x-ray spectrometry: Methods and techniques, 1993. 28. John J. Bozzola, Lonnie D. Russell, Electron Microscopy, 2nd edition. 29. D. A. Skoog and J. J. Leary, Principles of Instrumental Analysis, 4th edition. 30. 王應瓊, 儀器分析, 中央圖書出版社 31. Stephens, D.J. and V.J. Allan, Light microscopy techniques for live cell Imaging. Science, 2003. 300(5616): p. 82-
|